Special Investigation in Patients With Rheumatoid Arthritis (Combo Study; Adalimumab With High Dose Methotrexate)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01736189
Recruitment Status : Completed
First Posted : November 29, 2012
Last Update Posted : May 10, 2018
Information provided by (Responsible Party):
AbbVie ( AbbVie (prior sponsor, Abbott) )

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 16, 2018
  Actual Study Completion Date : April 16, 2018